Reliable mycoplasma detection for cell and gene therapy manufacturing combines rapid PCR based methods with compendial culture testing to catch contamination early and consistently at every checkpoint. Xellera Therapeutics operates a GMP compliant laboratory that builds mycoplasma screening into every stage of your program, from raw materials through in process and final lot release testing.